Development of CD388 as a long-lasting prophylactic anti-viral option for protection against the health impacts caused by influenza

Award NoticeNo Set AsideAwarded

This federal contract opportunity has been awarded to on September 30, 2025.

Award Information

This solicitation resulted in an award to for approximately $339,189,481 on September 30, 2025. Similar contracts are typically issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF under 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Award Number: 75A50125C00017
Award Amount: $339,189,481
Award Date: September 30, 2025

View full award details on USASpending.gov

Key Takeaways

No response deadline specified - contact the agency for details
Set-aside for No Set Aside businesses
Work to be performed in WASHINGTON, DC
Industry: Research and Development in Biotechnology (except Nanobiotechnology)

Contract Details

Notice ID: 75A50125C00017
Opportunity Type: Award Notice
Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-Agency: OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office: BARDA - ASPR / DAAPPO / BARDA DCMA
Posted Date: Tuesday, October 14, 2025
Response Deadline: Not specified
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC Code: AN13
Set-Aside: No Set Aside
Place of Performance: WASHINGTON, DC, 20515
Status: Active

View on SAM.gov

Description

No description available. View the full opportunity on SAM.gov for complete details.

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in WASHINGTON, DC. This set-aside designation means eligible businesses face reduced competition from larger firms.

Similar Opportunities

AJ11-VA Depleted Uranium Program PO 512C50314

VETERANS AFFAIRS, DEPARTMENT OF•MD

Q-RNAscope In-House Assay

HEALTH AND HUMAN SERVICES, DEPARTMENT OF•MD

Low-cost, Connected, Digital Lateral Flow Platform to Detect Influenza A, Influenza B, and SARS-Cov -2 for use in Over-the-Counter (OTC) Settings

HEALTH AND HUMAN SERVICES, DEPARTMENT OF•DC

A-High Throughput Transcriptomics (HTTr)

ENVIRONMENTAL PROTECTION AGENCY•OH

human-derived monoclonal antibodies (mAbs) and viral recombinant antigens (Ags)

DEPT OF DEFENSE•MD

Browse Related

More from HEALTH AND HUMAN SERVICES, DEPARTMENT OF

View all contracts from this agency

Contracts in DC

Browse opportunities in this state

Research and Development in Biotechnology (except Nanobiotechnology)

NAICS 541714 contracts

Looking for more opportunities?

Browse our full directory of government contracts

View All Contracts